Browse by Uncontrolled Keywords
Number of items: 9.
2011
Bujkiewicz, S;
Jones, HE;
Lai, MC;
Cooper, NJ;
Hawkins, N;
Squires, H;
Abrams, KR;
Spiegelhalter, DJ;
Sutton, AJ;
(2011)
Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.
Value in health, 14 (5).
pp. 768-76.
ISSN 1098-3015
DOI: https://doi.org/10.1016/j.jval.2010.12.002
2007
Bravo Vergel, Y;
Hawkins, NS;
Claxton, K;
Asseburg, C;
Palmer, S;
Woolacott, N;
Bruce, IN;
Sculpher, MJ;
(2007)
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis.
Rheumatology (Oxford, England), 46.
pp. 1729-35.
ISSN 1462-0324
DOI: https://doi.org/10.1093/rheumatology/kem221
Full text not available from this repository.
Weldon, SM;
Mullen, AC;
Loscher, CE;
Hurley, LA;
Roche, HM;
(2007)
Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid.
The Journal of nutritional biochemistry, 18 (4).
pp. 250-8.
ISSN 0955-2863
DOI: https://doi.org/10.1016/j.jnutbio.2006.04.003
Full text not available from this repository.
2006
Woolacott, N;
Bravo Vergel, Y;
Hawkins, N;
Kainth, A;
Khadjesari, Z;
Misso, K;
Light, K;
Asseburg, C;
Palmer, S;
Claxton, K;
+3 more...
Bruce, I;
Sculpher, M;
Riemsma, R;
(2006)
Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
Health technology assessment (Winchester, England), 10.
iii-iv, xiii-xvi, 1-239.
ISSN 1366-5278
https://researchonline.lshtm.ac.uk/id/eprint/2534859
2005
Moore, TA;
Lau, HY;
Cogen, AL;
Standiford, TJ;
(2005)
Defective innate antibacterial host responses during murine Klebsiella pneumoniae bacteremia: tumor necrosis factor (TNF) receptor 1 deficiency versus therapy with anti-TNF-alpha.
Clinical infectious diseases, 41 Sup.
S213-7.
ISSN 1058-4838
DOI: https://doi.org/10.1086/430126
Full text not available from this repository.
Siddiqui, AA;
Brouwer, AE;
Wuthiekanun, V;
Jaffar, S;
Shattock, R;
Irving, D;
Sheldon, J;
Chierakul, W;
Peacock, S;
Day, N;
+2 more...
White, NJ;
Harrison, TS;
(2005)
IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis.
Journal of immunology (Baltimore, Md, 174 (3).
pp. 1746-1750.
ISSN 0022-1767
DOI: https://doi.org/10.4049/jimmunol.174.3.1746
Full text not available from this repository.
2004
Engwerda, CR;
Ato, M;
Stager, S;
Alexander, CE;
Stanley, AC;
Kaye, PM;
(2004)
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of leishmania donovani infection.
The American journal of pathology, 165 (6).
pp. 2123-33.
ISSN 0002-9440
DOI: https://doi.org/10.1016/S0002-9440(10)63262-2
Full text not available from this repository.
2003
Moore, TA;
Lau, HY;
Cogen, AL;
Monteleon, CL;
Standiford, TJ;
(2003)
Anti-tumor necrosis factor-alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury.
Shock (Augusta, Ga), 20 (4).
pp. 309-15.
ISSN 1073-2322
DOI: https://doi.org/10.1097/01.shk.0000087203.34916.45
Full text not available from this repository.
Moore, TA;
Perry, ML;
Getsoian, AG;
Monteleon, CL;
Cogen, AL;
Standiford, TJ;
(2003)
Increased mortality and dysregulated cytokine production in tumor necrosis factor receptor 1-deficient mice following systemic Klebsiella pneumoniae infection.
Infection and immunity, 71 (9).
pp. 4891-900.
ISSN 0019-9567
DOI: https://doi.org/10.1128/IAI.71.9.4891-4900.2003
Full text not available from this repository.